HEADER TRANSFERASE 28-AUG-15 5DGS
TITLE CRYSTAL STRUCTURE OF HUMAN FPPS IN COMPLEX WITH THE MONOPHOSPHONATE
TITLE 2 COMPOUND 15
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: FARNESYL PYROPHOSPHATE SYNTHASE;
COMPND 3 CHAIN: F;
COMPND 4 FRAGMENT: UNP RESIDUES 72-419;
COMPND 5 SYNONYM: FPS,(2E,6E)-FARNESYL DIPHOSPHATE SYNTHASE,
COMPND 6 DIMETHYLALLYLTRANSTRANSFERASE,FARNESYL DIPHOSPHATE SYNTHASE,
COMPND 7 GERANYLTRANSTRANSFERASE;
COMPND 8 EC: 2.5.1.10,2.5.1.1;
COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: FDPS, FPS, KIAA1293;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_VARIANT: TUNER;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28
KEYWDS TRANSFERASE, ISOPRENE BIOSYNTHESIS, CHOLESTEROL BIOSYNTHESIS
EXPDTA X-RAY DIFFRACTION
AUTHOR J.M.RONDEAU,E.BOURGIER,S.LEHMANN
REVDAT 4 08-MAY-24 5DGS 1 REMARK
REVDAT 3 29-NOV-17 5DGS 1 REMARK
REVDAT 2 27-JUL-16 5DGS 1 JRNL
REVDAT 1 13-JUL-16 5DGS 0
JRNL AUTH W.JAHNKE,G.BOLD,A.L.MARZINZIK,S.OFNER,X.PELLE,S.COTESTA,
JRNL AUTH 2 E.BOURGIER,S.LEHMANN,C.HENRY,R.HEMMIG,F.STAUFFER,
JRNL AUTH 3 J.C.HARTWIEG,J.R.GREEN,J.M.RONDEAU
JRNL TITL A GENERAL STRATEGY FOR TARGETING DRUGS TO BONE.
JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 54 14575 2015
JRNL REFN ESSN 1521-3773
JRNL PMID 26457482
JRNL DOI 10.1002/ANIE.201507064
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH W.JAHNKE,J.M.RONDEAU,S.COTESTA,A.MARZINZIK,X.PELLE,M.GEISER,
REMARK 1 AUTH 2 A.STRAUSS,M.GOTTE,F.BITSCH,R.HEMMIG,C.HENRY,S.LEHMANN,
REMARK 1 AUTH 3 J.F.GLICKMAN,T.P.RODDY,S.J.STOUT,J.R.GREEN
REMARK 1 TITL ALLOSTERIC NON-BISPHOSPHONATE FPPS INHIBITORS IDENTIFIED BY
REMARK 1 TITL 2 FRAGMENT-BASED DISCOVERY.
REMARK 1 REF NAT.CHEM.BIOL. V. 6 660 2010
REMARK 1 REFN ESSN 1552-4469
REMARK 1 PMID 20711197
REMARK 1 DOI 10.1038/NCHEMBIO.421
REMARK 1 REFERENCE 2
REMARK 1 AUTH A.L.MARZINZIK,R.AMSTUTZ,G.BOLD,E.BOURGIER,S.COTESTA,
REMARK 1 AUTH 2 J.F.GLICKMAN,M.GOTTE,C.HENRY,S.LEHMANN,J.C.HARTWIEG,S.OFNER,
REMARK 1 AUTH 3 X.PELLE,T.P.RODDY,J.M.RONDEAU,F.STAUFFER,S.J.STOUT,A.WIDMER,
REMARK 1 AUTH 4 J.ZIMMERMANN,T.ZOLLER,W.JAHNKE
REMARK 1 TITL DISCOVERY OF NOVEL ALLOSTERIC NON-BISPHOSPHONATE INHIBITORS
REMARK 1 TITL 2 OF FARNESYL PYROPHOSPHATE SYNTHASE BY INTEGRATED LEAD
REMARK 1 TITL 3 FINDING.
REMARK 1 REF CHEMMEDCHEM V. 10 1884 2015
REMARK 1 REFN ESSN 1860-7187
REMARK 1 PMID 26381451
REMARK 1 DOI 10.1002/CMDC.201500338
REMARK 2
REMARK 2 RESOLUTION. 2.62 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.2
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.17
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 3 NUMBER OF REFLECTIONS : 14515
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.193
REMARK 3 R VALUE (WORKING SET) : 0.187
REMARK 3 FREE R VALUE : 0.243
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1451
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 7
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.83
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2922
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2149
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2628
REMARK 3 BIN R VALUE (WORKING SET) : 0.2086
REMARK 3 BIN FREE R VALUE : 0.2739
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.06
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 294
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2774
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 30
REMARK 3 SOLVENT ATOMS : 48
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 70.32
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.64480
REMARK 3 B22 (A**2) : 1.64480
REMARK 3 B33 (A**2) : -3.28950
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.494
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.281
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.468
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.282
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2866 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 3885 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1003 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 405 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2866 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 357 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 3632 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.11
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.61
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.33
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { F|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 10.1454 79.8974 26.6041
REMARK 3 T TENSOR
REMARK 3 T11: -0.3369 T22: -0.3439
REMARK 3 T33: 0.3978 T12: -0.0222
REMARK 3 T13: 0.0063 T23: 0.0476
REMARK 3 L TENSOR
REMARK 3 L11: 3.5057 L22: 2.0897
REMARK 3 L33: 2.1245 L12: 0.7786
REMARK 3 L13: -1.7105 L23: -0.7591
REMARK 3 S TENSOR
REMARK 3 S11: -0.1355 S12: -0.1827 S13: -0.5451
REMARK 3 S21: 0.0245 S22: 0.0196 S23: 0.2071
REMARK 3 S31: 0.1924 S32: -0.0266 S33: 0.1159
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5DGS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-AUG-15.
REMARK 100 THE DEPOSITION ID IS D_1000213179.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 18-APR-07
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 4.7
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178
REMARK 200 MONOCHROMATOR : MIRRORS
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS NOVEMBER 2005
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK AUGUST 2005
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14536
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.620
REMARK 200 RESOLUTION RANGE LOW (A) : 78.460
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 13.80
REMARK 200 R MERGE (I) : 0.11700
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.8400
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.62
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9
REMARK 200 DATA REDUNDANCY IN SHELL : 13.80
REMARK 200 R MERGE FOR SHELL (I) : 0.53700
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.570
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: CNX 2002
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 57.05
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2M SODIUM POTASSIUM PHOSPHATE, 25%
REMARK 280 GLYCEROL, PH 4.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.38600
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.48100
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.48100
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.69300
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.48100
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.48100
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 56.07900
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.48100
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.48100
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 18.69300
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.48100
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.48100
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 56.07900
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 37.38600
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4060 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 29070 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: F
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 110.96200
REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 110.96200
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 37.38600
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY F 4
REMARK 465 PRO F 5
REMARK 465 ASN F 6
REMARK 465 SER F 7
REMARK 465 ARG F 351
REMARK 465 ARG F 352
REMARK 465 LYS F 353
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN F 77 61.24 -106.34
REMARK 500 VAL F 124 -77.67 -85.92
REMARK 500 ALA F 178 78.99 -117.00
REMARK 500 LEU F 248 -76.66 -83.15
REMARK 500 ASN F 265 16.07 56.13
REMARK 500 LYS F 293 47.36 -80.60
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 5A7 F 401
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 5DGM RELATED DB: PDB
REMARK 900 5DGM IS THE FPPS COMPLEX WITH THE MONOPHOSPHONATE COMPOUND 7
REMARK 900 RELATED ID: 5DGN RELATED DB: PDB
REMARK 900 5DGN IS THE FPPS COMPLEX WITH COMPOUND 13
DBREF 5DGS F 6 353 UNP P14324 FPPS_HUMAN 72 419
SEQADV 5DGS GLY F 4 UNP P14324 EXPRESSION TAG
SEQADV 5DGS PRO F 5 UNP P14324 EXPRESSION TAG
SEQRES 1 F 350 GLY PRO ASN SER ASP VAL TYR ALA GLN GLU LYS GLN ASP
SEQRES 2 F 350 PHE VAL GLN HIS PHE SER GLN ILE VAL ARG VAL LEU THR
SEQRES 3 F 350 GLU ASP GLU MET GLY HIS PRO GLU ILE GLY ASP ALA ILE
SEQRES 4 F 350 ALA ARG LEU LYS GLU VAL LEU GLU TYR ASN ALA ILE GLY
SEQRES 5 F 350 GLY LYS TYR ASN ARG GLY LEU THR VAL VAL VAL ALA PHE
SEQRES 6 F 350 ARG GLU LEU VAL GLU PRO ARG LYS GLN ASP ALA ASP SER
SEQRES 7 F 350 LEU GLN ARG ALA TRP THR VAL GLY TRP CYS VAL GLU LEU
SEQRES 8 F 350 LEU GLN ALA PHE PHE LEU VAL ALA ASP ASP ILE MET ASP
SEQRES 9 F 350 SER SER LEU THR ARG ARG GLY GLN ILE CYS TRP TYR GLN
SEQRES 10 F 350 LYS PRO GLY VAL GLY LEU ASP ALA ILE ASN ASP ALA ASN
SEQRES 11 F 350 LEU LEU GLU ALA CYS ILE TYR ARG LEU LEU LYS LEU TYR
SEQRES 12 F 350 CYS ARG GLU GLN PRO TYR TYR LEU ASN LEU ILE GLU LEU
SEQRES 13 F 350 PHE LEU GLN SER SER TYR GLN THR GLU ILE GLY GLN THR
SEQRES 14 F 350 LEU ASP LEU LEU THR ALA PRO GLN GLY ASN VAL ASP LEU
SEQRES 15 F 350 VAL ARG PHE THR GLU LYS ARG TYR LYS SER ILE VAL LYS
SEQRES 16 F 350 TYR LYS THR ALA PHE TYR SER PHE TYR LEU PRO ILE ALA
SEQRES 17 F 350 ALA ALA MET TYR MET ALA GLY ILE ASP GLY GLU LYS GLU
SEQRES 18 F 350 HIS ALA ASN ALA LYS LYS ILE LEU LEU GLU MET GLY GLU
SEQRES 19 F 350 PHE PHE GLN ILE GLN ASP ASP TYR LEU ASP LEU PHE GLY
SEQRES 20 F 350 ASP PRO SER VAL THR GLY LYS ILE GLY THR ASP ILE GLN
SEQRES 21 F 350 ASP ASN LYS CYS SER TRP LEU VAL VAL GLN CYS LEU GLN
SEQRES 22 F 350 ARG ALA THR PRO GLU GLN TYR GLN ILE LEU LYS GLU ASN
SEQRES 23 F 350 TYR GLY GLN LYS GLU ALA GLU LYS VAL ALA ARG VAL LYS
SEQRES 24 F 350 ALA LEU TYR GLU GLU LEU ASP LEU PRO ALA VAL PHE LEU
SEQRES 25 F 350 GLN TYR GLU GLU ASP SER TYR SER HIS ILE MET ALA LEU
SEQRES 26 F 350 ILE GLU GLN TYR ALA ALA PRO LEU PRO PRO ALA VAL PHE
SEQRES 27 F 350 LEU GLY LEU ALA ARG LYS ILE TYR LYS ARG ARG LYS
HET 5A7 F 401 30
HETNAM 5A7 {(E)-2-[6-(ACETYLAMINO)-8-(NAPHTHALEN-1-YL)QUINOLIN-2-
HETNAM 2 5A7 YL]ETHENYL}PHOSPHONIC ACID
FORMUL 2 5A7 C23 H19 N2 O4 P
FORMUL 3 HOH *48(H2 O)
HELIX 1 AA1 ASP F 8 THR F 29 1 22
HELIX 2 AA2 GLU F 30 HIS F 35 1 6
HELIX 3 AA3 ILE F 38 ALA F 53 1 16
HELIX 4 AA4 TYR F 58 VAL F 72 1 15
HELIX 5 AA5 GLU F 73 GLN F 77 5 5
HELIX 6 AA6 ASP F 78 ASP F 107 1 30
HELIX 7 AA7 TRP F 118 LYS F 121 5 4
HELIX 8 AA8 VAL F 124 LEU F 126 5 3
HELIX 9 AA9 ASP F 127 ARG F 148 1 22
HELIX 10 AB1 TYR F 152 ALA F 178 1 27
HELIX 11 AB2 THR F 189 THR F 201 1 13
HELIX 12 AB3 THR F 201 ALA F 217 1 17
HELIX 13 AB4 GLY F 221 PHE F 249 1 29
HELIX 14 AB5 ASP F 251 GLY F 256 1 6
HELIX 15 AB6 SER F 268 ARG F 277 1 10
HELIX 16 AB7 THR F 279 TYR F 290 1 12
HELIX 17 AB8 GLU F 294 LEU F 308 1 15
HELIX 18 AB9 ASP F 309 ALA F 333 1 25
HELIX 19 AC1 PRO F 338 TYR F 349 1 12
SHEET 1 AA1 2 THR F 111 ARG F 112 0
SHEET 2 AA1 2 GLN F 115 ILE F 116 -1 O GLN F 115 N ARG F 112
CISPEP 1 ALA F 334 PRO F 335 0 3.65
SITE 1 AC1 19 TYR F 10 GLY F 56 LYS F 57 TYR F 58
SITE 2 AC1 19 ASN F 59 ARG F 60 THR F 63 GLN F 96
SITE 3 AC1 19 ARG F 113 SER F 205 PHE F 206 PHE F 239
SITE 4 AC1 19 GLN F 242 LEU F 344 LYS F 347 ILE F 348
SITE 5 AC1 19 LYS F 350 HOH F 503 HOH F 512
CRYST1 110.962 110.962 74.772 90.00 90.00 90.00 P 41 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009012 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009012 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013374 0.00000